Consequences of Tariffs on Pharmaceutical Products

That is the topic of a JMCP Viewpoint by Sean Sullivan, Jens Grueger, Aidan Sullivan, and Scott Ramsey. Some excerpts: The Budget Lab at Yale University projected that a 25% ad valorem tariff would increase medication costs by an “average of around $600 per year per household in the United States.”3 Tariffs can also create supply…

Read More

The Case for Patient Transportation Coverage for Health Plans

While health plans may consider the additional costs, long-term savings from reduced complications and hospital admissions can offset these expenses. Not only that, but transportation benefits can reduce health disparities and improve patient and caregiver lives. The post The Case for Patient Transportation Coverage for Health Plans appeared first on MedCity News.

Read More

Closing the CKD Care Gap with Value-Based Care Models

VBC models deliver significant benefits for CKD management by coordinating medical, behavioral, and social support through multidisciplinary teams. This approach enables providers to personalize care, address barriers to access, and use data-driven strategies to identify and prioritize high-risk patients. The post Closing the CKD Care Gap with Value-Based Care Models appeared first on MedCity News.

Read More